{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:00:59Z","timestamp":1793145659688,"version":"4.5.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100005642","name":"Universit\u00e0 degli Studi di Sassari","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005642","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s40261-022-01203-0","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T07:02:48Z","timestamp":1664002968000},"page":"921-935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Use of Azithromycin in Pregnancy: More Doubts than Certainties"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9767-7904","authenticated-orcid":false,"given":"Roberto","family":"Antonucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cuzzolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Locci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dessole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Capobianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,24]]},"reference":[{"issue":"10","key":"1203_CR1","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1093\/jac\/dkq307","volume":"65","author":"I Petersen","year":"2010","unstructured":"Petersen I, Gilbert R, Evans S, Ridolfi A, Nazareth I. Oral antibiotic prescribing during pregnancy in primary care: UK population-based study. J Antimicrob Chemother. 2010;65(10):2238\u201346.","journal-title":"J Antimicrob Chemother"},{"key":"1203_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/pds.3492","volume":"23","author":"L de Jonge","year":"2014","unstructured":"de Jonge L, Bos HJ, van Langen IM, de Jong-van den erg LT, Bakker MK. Antibiotics prescribed before, during and after pregnancy in the Netherlands: a drug utilization study. Pharmacoepidemiol Drug Saf. 2014;23:60\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1203_CR3","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/pds.4577","volume":"27","author":"A Engeland","year":"2018","unstructured":"Engeland A, Bj\u00f8rge T, Klungs\u00f8yr K, Hjellvik V, Skurtveit S, Furu K. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015. Pharmacoepidemiol Drug Saf. 2018;27:995\u20131004.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1203_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1186\/s12889-018-5545-z","volume":"18","author":"M Ventura","year":"2018","unstructured":"Ventura M, Maraschini A, D\u2019Aloja P, Kirchmayer U, Lega I, Davoli M, et al. Drug prescribing during pregnancy in a central region of Italy, 2008\u20132012. BMC Public Health. 2018;18:623.","journal-title":"BMC Public Health"},{"key":"1203_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2165\/00003088-199325050-00003","volume":"25","author":"NJ Lalak","year":"1993","unstructured":"Lalak NJ, Morris DL. Azithromycin clinical pharmacokinetics. Clin Pharmacokinet. 1993;25:370\u20134.","journal-title":"Clin Pharmacokinet"},{"key":"1203_CR6","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1128\/CMR.00078-09","volume":"23","author":"S Kanoh","year":"2010","unstructured":"Kanoh S, Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev. 2010;23:590\u2013615.","journal-title":"Clin Microbiol Rev"},{"key":"1203_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.pharmthera.2014.03.003","volume":"143","author":"MJ Parnham","year":"2014","unstructured":"Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, Perletti G, Verleden GM, Vos R. Azithromycin: mechanisms of action and their relevance for clinical application. Pharmacol Ther. 2014;143:225\u201345.","journal-title":"Pharmacol Ther"},{"key":"1203_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212212","volume":"14","author":"H Fan","year":"2019","unstructured":"Fan H, Li L, Wijlaars L, Gilbert RE. Associations between use of macrolide antibiotics during pregnancy and adverse child outcomes: a systematic review and meta-analysis. PLoS ONE. 2019;14: e0212212.","journal-title":"PLoS ONE"},{"issue":"2","key":"1203_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2163","volume":"31","author":"ME Oliver","year":"2021","unstructured":"Oliver ME, Hinks TSC. Azithromycin in viral infections. Rev Med Virol. 2021;31(2): e2163.","journal-title":"Rev Med Virol"},{"key":"1203_CR10","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1067\/mob.2003.171","volume":"188","author":"A Witt","year":"2003","unstructured":"Witt A, Sommer EM, Cichna M, Postlbauer K, Widhalm A, Gregor H, et al. Placental passage of clarithromycin surpasses other macrolide antibiotics. Am J Obstet Gynecol. 2003;188:816\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"1203_CR11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/sti.2002.004077","volume":"81","author":"S Mullick","year":"2005","unstructured":"Mullick S, Watson-Jones D, Beksinska M, Mabey D. Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm Infect. 2005;81:294\u2013302.","journal-title":"Sex Transm Infect."},{"key":"1203_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1128\/AAC.32.5.755","volume":"32","author":"FG Araujo","year":"1988","unstructured":"Araujo FG, Guptill DR, Remington JS. Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. Antimicr Agents Chemother. 1988;32:755\u20137.","journal-title":"Antimicr Agents Chemother."},{"key":"1203_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001166","volume":"2","author":"L Kalilani","year":"2007","unstructured":"Kalilani L, Mofolo I, Chaponda M, Rogerson SJ, Alker AP, Kwiek JJ, et al. A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women. PLoS ONE. 2007;2: e1166.","journal-title":"PLoS ONE"},{"key":"1203_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/1475-2875-7-255","volume":"7","author":"RM Chico","year":"2008","unstructured":"Chico RM, Pittrof R, Greenwood B, Chandramohan D. Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy. Malar J. 2008;7:255.","journal-title":"Malar J"},{"key":"1203_CR15","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0140-6736(08)61203-9","volume":"372","author":"S Kenyon","year":"2008","unstructured":"Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, Taylor DJ. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet. 2008;372:1319\u201327.","journal-title":"Lancet"},{"key":"1203_CR16","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1056\/NEJMoa1602044","volume":"375","author":"AT Tita","year":"2016","unstructured":"Tita AT, Szychowski JM, Boggess K, Saade G, Longo S, Clark E, et al. Adjunctive azithromycin prophylaxis for cesarean delivery. N Engl J Med. 2016;375:1231\u201341.","journal-title":"N Engl J Med"},{"key":"1203_CR17","unstructured":"Food and Drug Administration. FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms, 2013. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-azithromycin-zithromax-or-zmax-and-risk-potentially-fatal-heart. Accessed 10 Oct 2021."},{"key":"1203_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1517\/14740338.2015.989210","volume":"14","author":"ZK Lu","year":"2015","unstructured":"Lu ZK, Yuan J, Li M, Sutton SS, Rao GA, Jacob S, et al. Cardiac risks associated with antibiotics: azithromycin and levofloxacin. Expert Opin Drug Saf. 2015;14:295\u2013303.","journal-title":"Expert Opin Drug Saf"},{"key":"1203_CR19","first-page":"532","volume-title":"Encyclopedia of psychopharmacology","author":"S Preskorn","year":"2010","unstructured":"Preskorn S, Dahmen MM, Lincoln J. FDA pregnancy category. In: Stolerman IP, editor. Encyclopedia of psychopharmacology. Berlin, Heidelberg: Springer; 2010. p. 532."},{"key":"1203_CR20","doi-asserted-by":"publisher","first-page":"E625","DOI":"10.1503\/cmaj.161020","volume":"189","author":"FT Muanda","year":"2017","unstructured":"Muanda FT, Sheehy O, B\u0117rard A. Use of antibiotics during pregnancy and risk of spontaneous abortion. CMAJ. 2017;189:E625\u201333.","journal-title":"CMAJ"},{"key":"1203_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1001\/archpediatrics.2009.188","volume":"163","author":"KS Crider","year":"2009","unstructured":"Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med. 2009;163:978\u201385.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"1203_CR22","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1128\/AAC.01691-12","volume":"57","author":"A Bahat Dinur","year":"2013","unstructured":"Bahat Dinur A, Koren G, Matok I, Wiznitzer A, Uziel E, Gorodischer R, et al. Fetal safety of macrolides. Antimicrob Agents Chemother. 2013;57:3307\u201311.","journal-title":"Antimicrob Agents Chemother"},{"key":"1203_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2393-6-18","volume":"6","author":"M Sarkar","year":"2006","unstructured":"Sarkar M, Woodland C, Koren G, Einarson AR. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth. 2006;6:18.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1203_CR24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2165\/11630920-000000000-00000","volume":"35","author":"B Bar-Oz","year":"2012","unstructured":"Bar-Oz B, Weber-Schoendorfer C, Berlin M, Clementi M, Di Gianantonio E, de Vries L, et al. The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicenter, observational study. Drug Saf. 2012;35:589\u201398.","journal-title":"Drug Saf"},{"key":"1203_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n107","volume":"372","author":"NW Andersson","year":"2021","unstructured":"Andersson NW, Olsen RH, Andersen JT. Association between use of macrolides in pregnancy and risk of major birth defects: nationwide, register based cohort study. BMJ. 2021;372: n107.","journal-title":"BMJ"},{"key":"1203_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40264-019-00884-5","volume":"43","author":"N Mallah","year":"2020","unstructured":"Mallah N, Tohidinik HR, Etminan M, Figueiras A, Takkouche B. Prenatal exposure to macrolides and risk of congenital malformations: a meta-analysis. Drug Saf. 2020;43:211\u201321.","journal-title":"Drug Saf"},{"key":"1203_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-3-0348-8105-0_16","volume-title":"macrolide antibiotics","author":"NE Allen","year":"2002","unstructured":"Allen NE. Effects of macrolide antibiotics on ribosome function. In: Sch\u00f6nfeld M, Kirst HA, editors. macrolide antibiotics. Basel: Birkh\u00e4user Verlag; 2002. p. 261\u201380."},{"key":"1203_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1097-2765(02)00570-1","volume":"10","author":"JL Hansen","year":"2002","unstructured":"Hansen JL, Ippolito JA, Ban N, Nissen P, Moore PB, Steitz TA. The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol Cell. 2002;10:117\u201328.","journal-title":"Mol Cell"},{"key":"1203_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/jac\/25.suppl_A.115","volume":"25","author":"A Lassus","year":"1990","unstructured":"Lassus A. Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species. J Antimicr Chemother. 1990;25:115\u201321.","journal-title":"J Antimicr Chemother."},{"key":"1203_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/j.1875-9114.1992.tb04504.x","volume":"12","author":"RH Drew","year":"1992","unstructured":"Drew RH, Gallis HA. Azithromycin: spectrum of activity, pharmacokinetics, and clinical applications. Pharmacotherapy. 1992;12:161\u201373.","journal-title":"Pharmacotherapy"},{"key":"1203_CR31","first-page":"61","volume":"84","author":"MR Bush","year":"1994","unstructured":"Bush MR, Rosa C. Azithromycin and erythromycin in the treatment of cervical chlamydial infection during pregnancy. Obstet Gynecol. 1994;84:61\u20133.","journal-title":"Obstet Gynecol"},{"key":"1203_CR32","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/cid\/civ644","volume":"61","author":"A Lau","year":"2015","unstructured":"Lau A, Bradshaw CS, Lewis D, Fairley CK, Chen MY, Kong FY, et al. The efficacy of azithromycin for the treatment of genital Mycoplasma genitalium: a systematic review and meta-analysis. Clin Infect Dis. 2015;61:1389\u201399.","journal-title":"Clin Infect Dis"},{"key":"1203_CR33","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1086\/319258","volume":"183","author":"TB Hyde","year":"2001","unstructured":"Hyde TB, Gilbert M, Schwartz SB, Zell ER, Watt JP, Thacker WL, et al. Azithromycin prophylaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia. J Infect Dis. 2001;183:907\u201312.","journal-title":"J Infect Dis"},{"key":"1203_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1258\/0956462961917267","volume":"7","author":"HR Chang","year":"1996","unstructured":"Chang HR. The potential role of azithromycin in the treatment or prophylaxis of toxoplasmosis. Int J STD AIDS. 1996;7:18\u201322.","journal-title":"Int J STD AIDS"},{"key":"1203_CR35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.7326\/0003-4819-131-6-199909210-00007","volume":"131","author":"EW Hook","year":"1999","unstructured":"Hook EW, Stephens J, Ennis DM. Azithromycin compared with penicillin G benzathine for treatment of incubating syphilis. Ann Intern Med. 1999;131:434\u20137.","journal-title":"Ann Intern Med"},{"key":"1203_CR36","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1067\/mob.2003.141","volume":"188","author":"PS Ramsey","year":"2003","unstructured":"Ramsey PS, Vaules MB, Vasdev GM, Andrews WW, Ramin KD. Maternal and transplacental pharmacokinetics of azithromycin. Am J Obstet Gynecol. 2003;188:714\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"1203_CR37","first-page":"281","volume-title":"Macrolide antibiotics","author":"JA Sutcliffe","year":"2022","unstructured":"Sutcliffe JA, Leclerq R. Mechanisms of resistance to macrolides, lincosamides, and ketolides. In: Sch\u00f6nfeld M, Kirst HA, editors. Macrolide antibiotics. Basel: Birkh\u00e4user Verlag; 2022. p. 281\u2013317."},{"key":"1203_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1089\/mdr.2008.0806","volume":"14","author":"M Inoue","year":"2008","unstructured":"Inoue M, Farrell DJ, Kaneko K, Akizawa K, Fujita S, Kaku M, et al. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1\u20135 (1999\u20132004). Microb Drug Resist. 2008;14:109\u201317.","journal-title":"Microb Drug Resist"},{"key":"1203_CR39","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1473-3099(13)70036-7","volume":"13","author":"CD den Heijer","year":"2013","unstructured":"den Heijer CD, van Bijnen EM, Paget WJ, Pringle M, Goossens H, Bruggeman CA, et al. Prevalence and resistance of commensal Staphylococcus aureus, including methicillin-resistant S. aureus, in nine European countries: a cross-sectional study. Lancet Infect Dis. 2013;13:409\u201315.","journal-title":"Lancet Infect Dis"},{"key":"1203_CR40","unstructured":"AIFA (Agenzia Italiana del Farmaco) Farmaci utilizzabili per il trattamento della malattia COVID-19, 2022. https:\/\/www.aifa.gov.it\/aggiornamento-sui-farmaci-utilizzabili-per-il-trattamento-della-malattia-covid19. Accessed 15 May 2022."},{"key":"1203_CR41","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1128\/AAC.00771-09","volume":"54","author":"S Salman","year":"2010","unstructured":"Salman S, Rogerson SJ, Kose K, Griffin S, Gomorai S, Baiwog F, et al. Pharmacokinetic properties of azithromycin in pregnancy. Antimicrob Agents Chemother. 2010;54:360\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"1203_CR42","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0009-9236(97)90098-9","volume":"61","author":"DR Luke","year":"1997","unstructured":"Luke DR, Foulds G. Disposition of oral azithromycin in humans. Clin Pharmacol Ther. 1997;61:641\u20138.","journal-title":"Clin Pharmacol Ther"},{"key":"1203_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/jac\/47.1.61","volume":"47","author":"GW Amsden","year":"2001","unstructured":"Amsden GW, Gray CL. Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3-day period in healthy volunteers. J Antimicrob Chemother. 2001;47:61\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"1203_CR44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2307\/30147135","volume":"13","author":"MS Whitman","year":"1992","unstructured":"Whitman MS, Tunkel AR. Azithromycin and clarithromycin: overview and comparison with erythromycin. Infect Cont Hosp Epidemiol. 1992;13:357\u201368.","journal-title":"Infect Cont Hosp Epidemiol."},{"key":"1203_CR45","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/j.1365-2222.2012.03979.x","volume":"42","author":"EJ Cameron","year":"2012","unstructured":"Cameron EJ, McSharry C, Chaudhuri R, Farrow S, Thomson NC. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments. Clin Exp Allergy. 2012;42:1302\u201312.","journal-title":"Clin Exp Allergy"},{"key":"1203_CR46","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1128\/AAC.02067-13","volume":"58","author":"H Li","year":"2014","unstructured":"Li H, Liu DH, Chen LL, Zhao Q, Yu YZ, Ding JJ, et al. Adverse effects of long-term azithromycin use in patients with chronic lung diseases: a meta-analysis. Antimicrob Agents Chemother. 2014;58:511\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1203_CR47","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10840-007-9124-y","volume":"18","author":"A Kezerashvili","year":"2007","unstructured":"Kezerashvili A, Khattak H, Barsky A, Nazari R, Fisher JD. Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors. J Interv Card Electrophysiol. 2007;18:243\u20136.","journal-title":"J Interv Card Electrophysiol"},{"key":"1203_CR48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.clinthera.2013.02.012","volume":"35","author":"KA Mergenhagen","year":"2013","unstructured":"Mergenhagen KA, Olbrych PM, Mattapallil A, Krajewski MP, Ott MC. Effect of azithromycin on anticoagulation-related outcomes in geriatric patients receiving warfarin. Clin Ther. 2013;35:425\u201330.","journal-title":"Clin Ther"},{"key":"1203_CR49","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3949\/ccjm.80a.13077","volume":"80","author":"JR Giudicessi","year":"2013","unstructured":"Giudicessi JR, Ackerman MJ. Azithromycin and risk of sudden cardiac death: guilty as charged or falsely accused? Cleve Clin J Med. 2013;80:539\u201344.","journal-title":"Cleve Clin J Med"},{"key":"1203_CR50","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","volume":"366","author":"WA Ray","year":"2012","unstructured":"Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012;366:1881\u201390.","journal-title":"N Engl J Med"},{"key":"1203_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072148","volume":"8","author":"PM Coloma","year":"2013","unstructured":"Coloma PM, Schuemie MJ, Trifir\u00f2 G, Furlong L, van Mulligen E, Bauer-Mehren A, et al. Drug-induced acute myocardial infarction: identifying \u2018prime suspects\u2019 from electronic healthcare records-based surveillance system. PLoS ONE. 2013;8: e72148.","journal-title":"PLoS ONE"},{"key":"1203_CR52","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1155\/S1064744901000321","volume":"9","author":"J Kacmar","year":"2001","unstructured":"Kacmar J, Cheh E, Montagno A, Peipert JF. A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. Infect Dis Obstet Gynecol. 2001;9:197\u2013202.","journal-title":"Infect Dis Obstet Gynecol"},{"key":"1203_CR53","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ijantimicag.2007.04.015","volume":"30","author":"E Pitsouni","year":"2007","unstructured":"Pitsouni E, Iavazzo C, Athanasiou S, Falagas ME. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. Int J Antimicrob Agents. 2007;30:213\u201321.","journal-title":"Int J Antimicrob Agents"},{"key":"1203_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157045","volume":"11","author":"J Kimani","year":"2016","unstructured":"Kimani J, Phiri K, Kamiza S, Duparc S, Ayoub A, Rojo R, et al. Efficacy and safety of azithromycin-chloroquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa: an open-label, randomized trial. PLoS ONE. 2016;11: e0157045.","journal-title":"PLoS ONE"},{"key":"1203_CR55","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009346","volume":"96","author":"B Han","year":"2017","unstructured":"Han B, Sheng Y, Wang L, Feng H, Hou X, Li Y. Intrahepatic cholestasis of pregnancy or azithromycin-induced intrahepatic cholestasis: a case report. Medicine (Baltimore). 2017;96: e9346.","journal-title":"Medicine (Baltimore)"},{"key":"1203_CR56","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/jama.1997.03550120049032","volume":"278","author":"BM Mercer","year":"1997","unstructured":"Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA. 1997;278:989\u201395.","journal-title":"JAMA"},{"key":"1203_CR57","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0149-2918(96)80179-2","volume":"18","author":"GW Amsden","year":"1996","unstructured":"Amsden GW. Erythromicin, clarithromycin, and azithromycin: are the differences real? Clin Ther. 1996;18:56\u201372.","journal-title":"Clin Ther"},{"key":"1203_CR58","doi-asserted-by":"publisher","first-page":"2093530","DOI":"10.1155\/2020\/2093530","volume":"2020","author":"D Martingano","year":"2020","unstructured":"Martingano D, Singh S, Mitrofanova A. Azithromycin in the treatment of preterm prelabor rupture of membranes demonstrates a lower risk of chorioamnionitis and postpartum endometritis with an equivalent latency period compared with erythromycin antibiotic regimens. Infect Dis Obstet Gynecol. 2020;2020:2093530.","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"2","key":"1203_CR59","doi-asserted-by":"publisher","first-page":"144.e1","DOI":"10.1016\/j.ajog.2019.03.009","volume":"221","author":"R Navathe","year":"2019","unstructured":"Navathe R, Schoen CN, Heidari P, Bachilova S, Ward A, Tepper J, et al. Azithromycin vs erythromycin for the management of preterm premature rupture of membranes. Am J Obstet Gynecol. 2019;221(2):144.e1-144.e8.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"1203_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2021.100333","volume":"3","author":"MB Kole-White","year":"2021","unstructured":"Kole-White MB, Nelson LA, Lord M, Has P, Werner EF, Rouse DJ, et al. Pregnancy latency after preterm premature rupture of membranes: oral versus intravenous antibiotics. Am J Obstet Gynecol MFM. 2021;3(3): 100333.","journal-title":"Am J Obstet Gynecol MFM."},{"key":"1203_CR61","first-page":"1","volume":"64","author":"BE Hamilton","year":"2015","unstructured":"Hamilton BE, Martin JA, Osterman MJK, Curtin SC, Matthews TJ. Births: final data for 2014. Natl vital Stat Rep. 2015;64:1\u201364.","journal-title":"Natl Vital Stat Rep"},{"key":"1203_CR62","first-page":"69","volume":"5","author":"K Conroy","year":"2012","unstructured":"Conroy K, Koenig AF, Yu YH, Courtney A, Lee HJ, Norwitz ER. Infectious morbidity after cesarean delivery: 10 strategies to reduce risk. Rev Obstet Gynecol. 2012;5:69\u201377.","journal-title":"Rev Obstet Gynecol"},{"key":"1203_CR63","first-page":"289","volume":"101","author":"CJ Berg","year":"2003","unstructured":"Berg CJ, Chang J, Callaghan WM, Whitehead SJ. Pregnancy-related mortality in the United States, 1991\u20131997. Obstet Gynecol. 2003;101:289\u201396.","journal-title":"Obstet Gynecol"},{"key":"1203_CR64","first-page":"CD010485","volume":"9","author":"C Cluver","year":"2017","unstructured":"Cluver C, Novikova N, Eriksson DO, Bengtsson K, Lingman GK. Interventions for treating genital Chlamydia trachomatis infection in pregnancy. Cochrane Database Syst Rev. 2017;9:CD010485.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"1203_CR65","doi-asserted-by":"publisher","first-page":"e3836","DOI":"10.1093\/cid\/ciaa1112","volume":"73","author":"TH Skoff","year":"2021","unstructured":"Skoff TH, Faulkner AE, Liang JL, Barnes M, Kudish K, Thomas E, et al. Pertussis infections among pregnant women in the United States, 2012\u20132017. Clin Infect Dis. 2021;73(11):e3836\u201341.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1203_CR66","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccm.2010.10.004","volume":"32","author":"V Brito","year":"2011","unstructured":"Brito V, Niederman MS. Pneumonia complicating pregnancy. Clin Chest Med. 2011;32(1):121\u201332.","journal-title":"Clin Chest Med"},{"key":"1203_CR67","first-page":"CD001954","volume":"3","author":"M Laopaiboon","year":"2015","unstructured":"Laopaiboon M, Panpanich R, Swa MK. Azithromycin for acute lower respiratory tract infections. Cochrane Database Syst Rev. 2015;3:CD001954.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1203_CR68","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1093\/jpids\/pix044","volume":"7","author":"JD Cherry","year":"2018","unstructured":"Cherry JD. Treatment of Pertussis-2017. J Pediatric Infect Dis Soc. 2018;7(3):e123\u20135.","journal-title":"J Pediatric Infect Dis Soc."},{"issue":"13","key":"1203_CR69","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","volume":"290","author":"L Saiman","year":"2003","unstructured":"Saiman L, Marshall BC, Mayer-Hamblett N, Burns JL, Quittner AL, Cibene DA, et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA. 2003;290(13):1749\u201356.","journal-title":"JAMA"},{"issue":"2","key":"1203_CR70","doi-asserted-by":"publisher","first-page":"1901208","DOI":"10.1183\/13993003.01208-2019","volume":"55","author":"PG Middleton","year":"2020","unstructured":"Middleton PG, Gade EJ, Aguilera C, MacKillop L, Button BM, Coleman C, et al. ERS\/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases. Eur Respir J. 2020;55(2):1901208.","journal-title":"Eur Respir J"},{"issue":"3","key":"1203_CR71","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jcf.2020.08.003","volume":"20","author":"JL Taylor-Cousar","year":"2021","unstructured":"Taylor-Cousar JL, Jain R, Kazmerski TM, Aitken ML, West NE, Wilson A, et al. Concerns regarding the safety of azithromycin in pregnancy - relevance for women with cystic fibrosis. J Cyst Fibros. 2021;20(3):395\u20136.","journal-title":"J Cyst Fibros"},{"key":"1203_CR72","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejogrb.2008.07.008","volume":"141","author":"B Bar-Oz","year":"2008","unstructured":"Bar-Oz B, Diav-Citrin O, Shechtman S, Tellem R, Arnon J, Francetic I, et al. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study. Eur J Obstet Gynecol Reprod Biol. 2008;141:31\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1203_CR73","doi-asserted-by":"publisher","first-page":"221.e1","DOI":"10.1016\/j.ajog.2012.12.023","volume":"208","author":"KJ Lin","year":"2013","unstructured":"Lin KJ, Mitchell AA, Yau WP, Louik C, Hernandez-Diaz S. Safety of macrolides during pregnancy. Am J Obstet Gynecol. 2013;208:221.e1-221.e8.","journal-title":"Am J Obstet Gynecol"},{"key":"1203_CR74","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/pds.3900","volume":"24","author":"A B\u00e9rard","year":"2015","unstructured":"B\u00e9rard A, Sheehy O, Zhao JP, Nordeng H. Use of macrolides during pregnancy and the risk of birth defects: a population-based study. Pharmacoepidemiol Drug Saf. 2015;24:1241\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1203_CR75","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1111\/bcp.13364","volume":"83","author":"FT Muanda","year":"2017","unstructured":"Muanda FT, Sheehy O, B\u00e9rard A. Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study. Br J Clin Pharmacol. 2017;83:2557\u201371.","journal-title":"Br J Clin Pharmacol"},{"key":"1203_CR76","doi-asserted-by":"publisher","first-page":"648.e1","DOI":"10.1016\/j.ajog.2019.06.050","volume":"221","author":"P Damkier","year":"2019","unstructured":"Damkier P, Br\u00f8nniche LMS, Korch-Frandsen JFB, Broe A. In utero exposure to antibiotics and risk of congenital malformations: a population-based study. Am J Obstet Gynecol. 2019;221:648.e1-648.e15.","journal-title":"Am J Obstet Gynecol"},{"key":"1203_CR77","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/ped.13738","volume":"61","author":"SH Kim","year":"2019","unstructured":"Kim SH, Chun J, Ko KH, Sung TJ. Effect of antenatal azithromycin for Ureaplasma spp. on neonatal outcome at \u226430 weeks\u2019 gestational age. Pediatr Int. 2019;61:58\u201362.","journal-title":"Pediatr Int"},{"key":"1203_CR78","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00404-020-05569-4","volume":"302","author":"A Omranipoor","year":"2020","unstructured":"Omranipoor A, Kashanian M, Dehghani M, Sadeghi M, Baradaran HR. Association of antibiotics therapy during pregnancy with spontaneous miscarriage: a systematic review and meta-analysis. Arch Gynecol Obstet. 2020;302:5\u201322.","journal-title":"Arch Gynecol Obstet"},{"key":"1203_CR79","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1067\/S0002-9378(03)00777-4","volume":"189","author":"GG Kigozi","year":"2003","unstructured":"Kigozi GG, Brahmbhatt H, Wabwire-Mangen F, Wawer MJ, Serwadda D, Sewankambo N, et al. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai. Uganda Am J Obstet Gynecol. 2003;189:1398\u2013400.","journal-title":"Uganda. Am J Obstet Gynecol."},{"key":"1203_CR80","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.reprotox.2021.01.006","volume":"100","author":"AZ Leke","year":"2021","unstructured":"Leke AZ, Dolk H, Loane M, Casson K, Nelen V, Barisic I, et al. Macrolide and lincosamide antibiotic exposure in the first trimester of pregnancy and risk of congenital anomaly: a European case-control study. Reprod Toxicol. 2021;100:101\u20138.","journal-title":"Reprod Toxicol"},{"key":"1203_CR81","unstructured":"MHRA. Safety of macrolide antibiotics in pregnancy: a review of the epidemiological evidence, 2021. https:\/\/www.gov.uk\/government\/publications\/public-assessment-report-safety-of-macrolide-antibiotics-in-pregnancy-a-review-of-the-epidemiological-evidence\/safety-of-macrolide-antibiotics-in-pregnancy-a-review-of-the-epidemiological-evidence. Accessed 5 Dec 2021."},{"key":"1203_CR82","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1908","volume":"348","author":"M Lund","year":"2014","unstructured":"Lund M, Pasternak B, Davidsen RB, Feenstra B, Krogh C, Diaz LJ, et al. Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study. BMJ. 2014;348: g1908.","journal-title":"BMJ"},{"key":"1203_CR83","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00431-018-3287-7","volume":"178","author":"M Abdellatif","year":"2019","unstructured":"Abdellatif M, Ghozy S, Kamel MG, Elawady SS, Ghorab MME, Attia AW, et al. Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Eur J Pediatr. 2019;178:301\u201314.","journal-title":"Eur J Pediatr"},{"key":"1203_CR84","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13052-019-0613-2","volume":"45","author":"HH Almaramhy","year":"2019","unstructured":"Almaramhy HH, Al-Zalabani AH. The association of prenatal and postnatal macrolide exposure with subsequent development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Ital J Pediatr. 2019;45:20.","journal-title":"Ital J Pediatr"},{"key":"1203_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122034","volume":"10","author":"WH Meeraus","year":"2015","unstructured":"Meeraus WH, Petersen I, Gilbert R. Association between Antibiotic prescribing in pregnancy and cerebral palsy or epilepsy in children born at term: a cohort study using the Health Improvement Network. PLoS ONE. 2015;10: e0122034.","journal-title":"PLoS ONE"},{"key":"1203_CR86","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/cea.12356","volume":"45","author":"J Mets\u00e4l\u00e4","year":"2015","unstructured":"Mets\u00e4l\u00e4 J, Lundqvist A, Virta LJ, Kaila M, Gissler M, Virtanen SM. Prenatal and post-natal exposure to antibiotics and risk of asthma in childhood. Clin Exp Allergy. 2015;45:137\u201345.","journal-title":"Clin Exp Allergy"},{"key":"1203_CR87","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/cea.12756","volume":"46","author":"B Mulder","year":"2016","unstructured":"Mulder B, Pouwels KB, Schuiling-Veninga CCM, Bos HJ, de Vries TW, Jick SS, et al. Antibiotic use during pregnancy and asthma in preschool children: the influence of confounding. Clin Exp Allergy. 2016;46:1214\u201326.","journal-title":"Clin Exp Allergy"},{"key":"1203_CR88","doi-asserted-by":"publisher","first-page":"1702070","DOI":"10.1183\/13993003.02070-2017","volume":"52","author":"K Loewen","year":"2018","unstructured":"Loewen K, Monchka B, Mahmud SM, Jong G, Azad MB. Prenatal antibiotic exposure and childhood asthma: a population-based study. Eur Respir J. 2018;52:1702070.","journal-title":"Eur Respir J"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01203-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-022-01203-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01203-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T10:06:21Z","timestamp":1667124381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-022-01203-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,24]]},"references-count":88,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1203"],"URL":"https:\/\/doi.org\/10.1007\/s40261-022-01203-0","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,24]]},"assertion":[{"value":"13 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by Universit\u00e0 degli Studi di Sassari within the CRUI-CARE Agreement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors report no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"RA, LC, CL, and GC designed the study; LC, CL, and FD collected and analyzed data; CL, LC, GC, FD, and RA wrote the manuscript; LC and FD gave technical support and conceptual advice; LC, CL, and RA contributed to manuscript revisions. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}